The anti-MDA5 antibody is associated with a high incidence of ILD in DM/CADM patients [34], especially rapidly progressive ILD with respiratory failure and fatal outcomes [37,38,39,40]. This evidence concerns the gene IFIH1 and interstitial lung disease.